Education
About Us
Working with TipRanks
Follow Us
CV Sciences Inc (CVSI)
OTHER OTC:CVSI
CVSI Stock Chart & Stats
$0.09
>-$0.01(-7.69%)
At close: 4:00 PM EST
$0.09
>-$0.01(-7.69%)
Day’s Range― - ―
52-Week Range$0.02 - $0.10
Previous CloseN/A
Volume110.38K
Average Volume (3M)246.65K
Market Cap
$12.65M
Enterprise Value$13.51M
Total Cash (Recent Filing)$381.00K
Total Debt (Recent Filing)$860.00K
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding184,263,660
10 Day Avg. Volume158,629
30 Day Avg. Volume246,649
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.31
Price to Sales (P/S)0.38
P/FCF Ratio-6.75
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue0.94
Enterprise Value/Gross Profit2.00
Enterprise Value/Ebitda-16.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product InnovationThe introduction of new products can drive organic growth by expanding the product line and attracting new customers, enhancing long-term revenue potential.
Gross Margin StabilityStable gross margins indicate effective cost management and pricing strategies, which are crucial for sustaining profitability over time.
Strategic M&A OpportunitiesExploring M&A opportunities can lead to strategic growth, market expansion, and increased shareholder value, supporting long-term business development.
Bears Say
Declining RevenueA declining revenue trend can indicate weakening market demand or competitive pressures, potentially impacting long-term financial health and growth prospects.
Negative Cash FlowNegative cash flow suggests difficulties in generating sufficient cash from operations, which can hinder investment in growth opportunities and strain liquidity.
High Leverage RiskHigh leverage can increase financial risk, limit flexibility, and lead to higher interest expenses, affecting the company's ability to invest in future growth.
CV Sciences News
CVSI FAQ
What was CV Sciences Inc’s price range in the past 12 months?
CV Sciences Inc lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
What is CV Sciences Inc’s market cap?
CV Sciences Inc’s market cap is $12.65M.
When is CV Sciences Inc’s upcoming earnings report date?
CV Sciences Inc’s upcoming earnings report date is Mar 26, 2026 which is in 21 days.
How were CV Sciences Inc’s earnings last quarter?
CV Sciences Inc released its earnings results on Nov 13, 2025. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is CV Sciences Inc overvalued?
According to Wall Street analysts CV Sciences Inc’s price is currently Overvalued.
Does CV Sciences Inc pay dividends?
CV Sciences Inc does not currently pay dividends.
What is CV Sciences Inc’s EPS estimate?
CV Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CV Sciences Inc have?
CV Sciences Inc has 184,263,660 shares outstanding.
What happened to CV Sciences Inc’s price movement after its last earnings report?
CV Sciences Inc reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CV Sciences Inc?
Currently, no hedge funds are holding shares in CVSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CV Sciences Inc
CV Sciences, Inc. (CVSI) is a biotechnology company focused on the research, development, and commercialization of products derived from hemp extract, particularly those containing cannabidiol (CBD). Operating primarily in the wellness and pharmaceutical sectors, CV Sciences offers a range of products including dietary supplements, topical applications, and pharmaceutical formulations aimed at promoting health and well-being. The company is dedicated to providing high-quality, science-backed products that leverage the therapeutic potential of cannabinoids.
CVSI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant improvements in gross margin, cash flow, and cost efficiency, alongside successful new product developments and strategic M&A integration. However, challenges such as revenue decline, regulatory issues, and a decrease in B2C revenue were noted. Despite these challenges, the company's positive adjusted EBITDA and improved financial metrics demonstrate progress towards profitability.View all CVSI earnings summariesTechnical Analysis
cbdMD
―
Cosmos Holdings
―
IM Cannabis Corp
―
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---